Company / FCF Margin
AVADEL PHARMACEUTICALS PLC FCF Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-27.7%
FY2024
5-year range
-27.7% / -27.7%
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#75 of 134
Health Care
What the data says
FCF Margin changed -399% YoY in FY2024, a notable deviation from the 3-year average annual change of -165%.
Based on SEC 10-K filings.
-27.7% in FY2024.
Declined from 11.8% to -27.7% over the past 8 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#75 of 134 in Health CareTop 56% of 134This company -27.7% Sector average -637.8%
▼
+95.7% above sector average
Key checks
Key Insights
- Currently 610.0pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -27.7% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 9.3% | -21.2% |
| FY2016 | 11.8% | -75.3% |
| FY2015 | 47.8% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026